CAMPELLO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.864
AS - Asia 6.066
EU - Europa 3.920
AF - Africa 1.605
SA - Sud America 1.376
OC - Oceania 158
Continente sconosciuto - Info sul continente non disponibili 76
Totale 25.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.982
SG - Singapore 2.289
CN - Cina 981
BR - Brasile 831
IT - Italia 747
HK - Hong Kong 667
VN - Vietnam 517
DE - Germania 423
FI - Finlandia 340
PL - Polonia 214
NL - Olanda 193
GB - Regno Unito 191
SE - Svezia 169
RU - Federazione Russa 154
FR - Francia 132
IN - India 122
AR - Argentina 106
IE - Irlanda 102
AT - Austria 99
MX - Messico 90
TR - Turchia 88
ZA - Sudafrica 83
IQ - Iraq 81
UA - Ucraina 77
ES - Italia 74
EC - Ecuador 69
BJ - Benin 68
ID - Indonesia 65
CA - Canada 63
JP - Giappone 59
CI - Costa d'Avorio 58
EG - Egitto 58
CL - Cile 57
UY - Uruguay 57
SA - Arabia Saudita 55
CO - Colombia 54
KR - Corea 54
NP - Nepal 54
AE - Emirati Arabi Uniti 52
AO - Angola 52
HN - Honduras 51
AL - Albania 50
MD - Moldavia 50
AZ - Azerbaigian 49
GR - Grecia 49
PH - Filippine 49
VE - Venezuela 49
DO - Repubblica Dominicana 48
CH - Svizzera 47
JM - Giamaica 47
MG - Madagascar 47
AU - Australia 46
BF - Burkina Faso 46
LV - Lettonia 46
ML - Mali 46
TT - Trinidad e Tobago 46
CR - Costa Rica 45
DZ - Algeria 45
KE - Kenya 45
LB - Libano 45
PA - Panama 45
RS - Serbia 45
CZ - Repubblica Ceca 44
ME - Montenegro 44
NI - Nicaragua 44
PE - Perù 44
UZ - Uzbekistan 44
CW - ???statistics.table.value.countryCode.CW??? 43
GE - Georgia 43
LA - Repubblica Popolare Democratica del Laos 43
LY - Libia 43
PR - Porto Rico 43
TJ - Tagikistan 43
CG - Congo 42
IS - Islanda 42
MY - Malesia 42
RO - Romania 42
UG - Uganda 42
YT - Mayotte 42
ZM - Zambia 42
BG - Bulgaria 41
BW - Botswana 41
CU - Cuba 41
MR - Mauritania 41
PY - Paraguay 41
CY - Cipro 40
HU - Ungheria 40
IL - Israele 40
LC - Santa Lucia 40
BS - Bahamas 39
GT - Guatemala 39
NO - Norvegia 39
PK - Pakistan 39
PS - Palestinian Territory 39
SI - Slovenia 39
GM - Gambi 38
KZ - Kazakistan 38
MA - Marocco 38
TZ - Tanzania 38
HR - Croazia 37
Totale 23.223
Salva come PNG Salva come JPEG
Città #
Fairfield 1.412
Ashburn 1.375
Singapore 1.252
Woodbridge 808
Chandler 662
Hong Kong 636
Houston 583
Seattle 566
Ann Arbor 523
Cambridge 455
Wilmington 450
Beijing 361
Santa Clara 313
Chicago 250
Los Angeles 246
Boardman 230
Munich 210
Helsinki 175
Ho Chi Minh City 160
San Diego 154
Padova 148
Princeton 132
Bytom 129
Medford 128
Des Moines 107
Salt Lake City 105
Villafranca Padovana 105
Dong Ket 102
New York 100
Buffalo 98
Dublin 87
Hanoi 75
Hefei 71
São Paulo 69
Roxbury 67
Cotonou 64
Vienna 55
Abidjan 53
Turku 53
Nuremberg 52
Warsaw 52
Elk Grove Village 51
Stockholm 51
Dallas 50
London 49
Montevideo 49
Lappeenranta 47
Baku 46
Milan 45
Tampa 45
Antananarivo 44
Luanda 44
Bamako 42
Brooklyn 42
Managua 42
Panama City 42
Dushanbe 41
Lusaka 41
Kampala 40
Vientiane 39
Nairobi 38
Riga 38
Castries 37
Dakar 37
Johannesburg 37
Nanjing 37
Nassau 37
Tashkent 37
Amman 36
Nouakchott 36
San José 36
Ulan Bator 36
Libreville 35
Podgorica 35
Rio de Janeiro 35
Andorra la Vella 34
Havana 34
Ouagadougou 34
Phnom Penh 34
Reykjavik 34
Willemstad 34
Gaborone 33
Redondo Beach 32
Tripoli 32
Harare 31
Poplar 31
Tokyo 31
Bishkek 30
Dar es Salaam 30
Padua 30
Athens 29
Conakry 29
Montreal 29
Chennai 28
Accra 27
Atlanta 27
Bridgetown 27
Guatemala City 27
Rome 27
Sofia 27
Totale 14.831
Salva come PNG Salva come JPEG
Nome #
Whole blood thromboelastometry profiles in women with preeclampsia 318
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 271
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 259
Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study 243
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 235
Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study 233
Dynamics of circulating microparticles in obesity after weight loss 221
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 218
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 213
A bit deeper on hypercoagulability and cancer: focus on longitudinal trend of procoagulant microvesicles in gastro-intestinal malignancy 207
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 203
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 199
More on Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies 197
Association between ABO blood group and bleeding phenotype in patients with mild rare bleeding disorders 195
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure 193
COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward 193
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 188
The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement 183
Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study 181
ABO blood group and the risk of post-thrombotic syndrome 181
Predictors of postoperative bleeding in children undergoing cardiopulmonary bypass: A preliminary Italian study 180
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 180
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 179
More severe hypercoagulable state in acute COVID-19 pneumonia as compared to other pneumonia 179
Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia 178
On-treatment platelet reactivity in peripheral and coronary blood in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI) 176
The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein i antibodies. A comparison with a homemade ELISA method 175
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 175
Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery 175
Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events 173
Microparticles as biomarkers of venous thromboembolic events 173
Thromboelastometry profiles in patients undergoing thrombolytic therapy for acute ischaemic stroke 172
The diagnostic challenge: are we missing pulmonary embolism diagnosis in patients with syncope? 171
Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit 171
CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma 171
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 169
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 169
Incidence of VTE in asymptomatic children with deficiencies of antithrombin, protein C, and protein S: a prospective cohort study 169
Anti-platelet factor 4 antibody-mediated disorders: an updated narrative review 168
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients 168
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 167
Clinical and laboratory characteristics of isolated lupus anticoagulants 164
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 163
Short-term exposure to high levels of air pollution as a risk factor for acute isolated pulmonary embolism. 162
Pierce the ear and stab the spleen 162
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 162
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 161
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 160
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 159
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 159
Factor VIIa-antithrombin complexes in children with ischemic stroke. 158
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 158
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 157
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 155
The current understanding of trauma-induced coagulopathy (TIC): a focused review on pathophysiology 153
ABO blood groups and the risk of retinal vein occlusion 152
Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women 150
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 150
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 150
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: A role for circulating microparticles? 148
Thrombophilia, risk factors and prevention 147
Evaluation of a procoagulant phospholipid functional assay as a routine test for measuring circulating microparticle activity. 145
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 145
Cardiac injury and COVID-19 associated coagulopathy in patients with acute SARS-CoV-2 pneumonia: A rotational thromboelastometry study 145
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 143
Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project 142
Factor V Leiden paradox and the occurrence of distal vein thrombosis in a large cohort of thrombotic patients 142
Thrombophilia and the risk of post-thrombotic syndrome: Retrospective cohort observation 142
The haemostatic system in acromegaly: a single-centre case–control study 142
The prognostic role of ThromboDynamic Index in patients with severe sepsis 141
Whole blood hypocoagulable profile correlates with the greater risk of death at 28 days in patients with severe sepsis 140
The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study 140
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 140
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. 139
Treatment of venous thromboembolism: the single-drug approach 138
Hyperacute Valve Thrombosis After Transapical Transcatheter Aortic Valve Replacement in a Patient With Polycythemia Vera 138
Circulating glial-derived and tissue factor bearing microparticles in patients with high grade glioma 137
"Hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: Facts or technical artifacts? 137
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey 136
Local prothrombotic state in portal venous system in cirrhosis 136
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation 134
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review 134
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 134
Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism. 133
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 132
Factor VIIa-antithrombin complex: A possible new biomarker for activated coagulation 132
Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. 132
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 132
DOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study 132
Thrombotic risk following video-assisted thoracoscopic surgery versus open thoracotomy: a systematic review and meta-analysis 131
Thrombophilia and the risk of the post-thrombotic syndrome: retrospective cohort observation. 130
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 129
Padua FIXa resistance to Protein S and a potential therapy for hyperactive FIXa 129
Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis. 128
Improving care for individuals with gender incongruence: Establishing a multidisciplinary approach in Italy 127
Optimal duration of anticoagulation: Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests 127
Viscoelastic testing in benign hematologic disorders: Clinical perspectives and future implications of point-of-care testing to assess hemostatic competence 126
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 126
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 125
Circulating microparticles in carriers of prothrombin G20210A mutation. 125
Totale 16.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.419
article - articoli 76.819
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.238
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.525 0 0 0 0 262 61 90 222 205 243 184 258
2021/20221.768 83 148 190 88 128 137 72 171 123 66 157 405
2022/20231.358 251 136 33 147 237 183 12 80 153 24 79 23
2023/20241.017 26 141 120 111 64 147 74 38 31 55 82 128
2024/20254.866 21 380 214 161 530 169 287 396 491 185 802 1.230
2025/202611.301 1.032 1.470 2.846 3.640 2.313 0 0 0 0 0 0 0
Totale 25.364